Associate Professor Ki-Bum Lee has developed patent-pending technology that may overcome one of the critical barriers to harnessing the full therapeutic potential of stem cells.
One of the major challenges facing researchers interested in regenerating cells and growing new tissue to treat debilitating injuries and diseases such as Parkinson’s disease, heart disease, and spinal cord trauma, is creating an easy, effective, and non-toxic methodology to control differentiation into specific cell lineages. Lee and colleagues at Rutgers and Kyoto University in Japan have invented a platform they call NanoScript, an important breakthrough for researchers in the area of gene expression. Gene expression is the way information encoded in a gene is used to direct the assembly of a protein molecule, which is integral to the process of tissue development through stem cell therapeutics.
Stem cells hold great promise for a wide range of medical therapeutics as they have the ability to grow tissue throughout the body. In many tissues, stem cells have an almost limitless ability to divide and replenish other cells, serving as an internal repair system.
Transcription factor (TF) proteins are master regulators of gene expression. TF proteins play a pivotal role in regulating stem cell differentiation. Although some have tried to make synthetic molecules that perform the functions of natural transcription factors, NanoScript is the first nanomaterial TF protein that can interact with endogenous DNA. ACS Nano, a publication of the American Chemical Society (ACS), has published Lee’s research on NanoScript. The research is supported by a grant from the National Institutes of Health (NIH).
“Our motivation was to develop a highly robust, efficient nanoparticle-based platform that can regulate gene expression and eventually stem cell differentiation,” said Lee, who leads a Rutgers research group primarily focused on developing and integrating nanotechnology with chemical biology to modulate signaling pathways in cancer and stem cells. “Because NanoScript is a functional replica of TF proteins and a tunable gene-regulating platform, it has great potential to do exactly that. The field of stem cell biology now has another platform to regulate differentiation while the field of nanotechnology has demonstrated for the first time that we can regulate gene expression at the transcriptional level.”
NanoScript was constructed by tethering functional peptides and small molecules called synthetic transcription factors, which mimic the individual TF domains, onto gold nanoparticles.
“NanoScript localizes within the nucleus and initiates transcription of a reporter plasmid by up to 30-fold,” said Sahishnu Patel, Rutgers Chemistry graduate student and co-author of the ACS Nano publication. “NanoScript can effectively transcribe targeted genes on endogenous DNA in a nonviral manner.”
The Latest on: Stem Cell Therapeutics
via Google News
The Latest on: Stem Cell Therapeutics
- Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapyon October 13, 2019 at 10:13 pm
Although PD-L1/PD-1 blockade therapy has been approved to treat many types of cancers ... Instead, B7-H3, another checkpoint molecule, was highly expressed by both tumor cells and tumor-infiltrating ...
- Early Promise for Gene Therapy in AMDon October 13, 2019 at 2:32 pm
Asked how long the therapy might allow patients to go without additional treatment ... The most common were anterior chamber cells (four, two moderate), anterior chamber flare (four), vitreous cells ...
- This Biotech Is Developing a Stem Cell Therapy for Deafnesson October 11, 2019 at 3:08 am
Sheffield is one of the UK’s historic industrial bases. It also hosts the biotech Rinri Therapeutics, which is developing a stem cell therapy to treat deaf patients who are not eligible for cochlear ...
- Sarah Ferguson gets candid on using Botox, laser facelifts and stem cell therapy for her feeton October 11, 2019 at 2:07 am
And her face wasn’t the only thing Ferguson focused on. According to the outlet, Ferguson traveled to the Bahamas earlier this year to have regenerative stem cell therapy on her feet. “I think my toes ...
- Frequency Therapeutics Commences Dosing in its Phase 2a Study of FX-322 for Sensorineural Hearing Loss; FDA Grants FX-322 Fast Track Designationon October 10, 2019 at 5:05 pm
Frequency Therapeutics is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The company’s progenitor cell activation (PCA) ...
- Global Stem Cell Therapy Market Will Grow at a CAGR of 11.0% - Exclusive Report by MarketsandMarkets™on October 10, 2019 at 6:27 am
[120 Pages Report] The global stem cell therapy market is estimated to reach USD 145.8 million by 2021, growing at a CAGR of 11.0% during the forecast period This press release was orginally ...
- Targeting immune cells may be potential therapy for Alzheimer'son October 10, 2019 at 6:01 am
Holtzman and colleagues previously had shown that microglia limit the development of a harmful form of tau. But the researchers also suspected that microglial cells could be a double-edged sword.
- CAR T-cell therapy may be effective in killing solid tumor cellson October 2, 2019 at 10:52 am
A form of leukemic immunotherapy known as chimeric antigen receptors (CAR) T-cell therapy may also be effective in killing solid tumor cells coated in specific antibodies, the researchers say. The ...
- Chronic joint pain stem cell therapy regenerative medicineon October 2, 2019 at 6:00 am
But it doesn’t have to be so disruptive because there are plenty of options to combat this pain. One of those popular, noninvasive options is regenerative medicine and stem cell therapy. Though this ...
- Regenerative Stem Cell Therapy Pioneer, Celavie Biosciences, LLC, to Attend Cell & Gene Meeting on the Mesa on October 2 – 4 in Carlsbad, Californiaon October 1, 2019 at 7:06 am
Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics ... a privately-held company whose mission is to improve lives and ...
via Bing News